A closer look at NCMM's recent annual Network Meeting at Oslo Science Park
Science communication took on a whole new meaning when NCMM Group Leader, Irep Gözen, head of the Bionanotechnology and Membrane Systems Group, addressed thousands of students on Wednesday 6 December.
Findings of study from NCMM Group Leaders, together with collaborators at Institute for Cancer Research at Oslo University Hospital, published in Nature Communications
NCMM Associate Investigator Professor Per Lønning is joint lead-author on a recent publication that has caught the media’s attention.
Event designed to inform Norwegian researchers about the opportunities for studying, training and working at the European Molecular Biology Laboratory (EMBL).
Trial to determine how aspirin can improve disease free survival in patients treated with resection for colorectal cancer liver metastases (CRCLM) is now underway.
NCMM and EATRIS Norway have been awarded a grant from the Helse-EU programme at the Research Council of Norway to recruit an EATRIS (European Infrastructure for Translational Medicine) Coordinator.
Irep Gözen is the Lead of the Programmable Cell-like Compartments convergence environment, which was recently awarded funding by UiO: Life Science
The annual NLS Days conference took place on 12-14 September at the Malmö Convention Centre in Sweden.
Professor Per Ottar Seglen, a guest researcher at NCMM, has been awarded the prestigious King Olav V’s Prize for Cancer Research 2017.
NCMM is pleased to announce that its Director, Professor Kjetil Taskén, has been formally appointed to the IMI Scientific Committee.
NCMM is delighted to congratulate Senior Engineer on receiving the UiO Prize for outstanding work for Health Environment and Safety (HSE) in the workplace.
The merger between Centre for Molecular Medicine Norway (NCMM) and the Biotechnology Centre of Oslo (BiO) formally came into effect on 2 January 2017.
The NCMM Annual Report is now available online.
August edition of the NCMM monthly newsletter is now available
NCMM is very pleased to announce that Professor Olli Kallioniemi has been appointed as the new NCMM Scientific Advisory Board (SAB) member. He will succeed Leif Groop.
NCMM’s Director, Professor Kjetil Taskén, has been interviewed by the University of Oslo’s flagship science and technology news outlet, Titan.uio.no, ahead of his appearance at the Oslo Life Science Conference on the 16 February.
Director of NCMM, Professor Kjetil Taskén, has been appointed as the Head and Director of Institute for Cancer Research Oslo University Hospital (OUH)